1. Home
  2. GP vs ACXP Comparison

GP vs ACXP Comparison

Compare GP & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GreenPower Motor Company Inc.

GP

GreenPower Motor Company Inc.

HOLD

Current Price

$1.23

Market Cap

6.4M

ML Signal

HOLD

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.59

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GP
ACXP
Founded
2010
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
8.3M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
GP
ACXP
Price
$1.23
$1.59
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$95.50
AVG Volume (30 Days)
126.8K
82.2K
Earning Date
02-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.29
52 Week High
$4.00
$8.34

Technical Indicators

Market Signals
Indicator
GP
ACXP
Relative Strength Index (RSI) 69.59 32.95
Support Level $0.88 $1.37
Resistance Level $1.37 $2.26
Average True Range (ATR) 0.07 0.11
MACD 0.01 -0.00
Stochastic Oscillator 80.77 9.80

Price Performance

Historical Comparison
GP
ACXP

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: